Aprea Therapeutics, Inc. Earnings Per Share (Basic)
Aprea Therapeutics, Inc. (APRE) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Aprea Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
- Aprea Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.22.
- Aprea Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.32.
- Aprea Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.47.
- Aprea Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.93.
- Aprea Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.35.
- Aprea Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$3.95.
- Aprea Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$67.99.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.07 10-Q · filed 2026-08-12 | -$0.20 10-Q · filed 2026-08-12 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2026-03-31 | -$0.22 10-Q · filed 2026-05-13 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.93 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | -$0.47 10-Q · filed 2025-11-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.65 10-Q · filed 2025-11-12 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-06-30 | -$0.53 10-Q · filed 2026-08-12 | -$1.19 10-Q · filed 2026-08-12 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.31 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-03-31 | -$0.66 10-Q · filed 2026-05-13 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.78 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2024-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$1.71 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$2.35 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | -$0.64 10-Q · filed 2025-11-12 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.88 10-Q · filed 2025-11-12 | -$2.73 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.58 10-Q · filed 2025-08-12 | -$1.24 10-Q · filed 2025-08-12 | -$2.10 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$2.94 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-03-31 | -$0.67 10-Q · filed 2025-05-14 | -$1.58 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$2.43 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$3.30 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2023-12-31 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$1.78 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$2.65 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$3.95 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | -$0.86 10-Q · filed 2024-11-07 | -$1.73 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$3.03 10-Q · filed 2024-11-07 | -$3.97 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2023-06-30 | -$0.87 10-Q · filed 2024-08-12 | -$2.18 10-Q · filed 2024-08-12 | -$3.13 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$4.96 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2023-03-31 | -$1.34 10-Q · filed 2024-05-14 | -$2.30 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$4.25 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$49.67 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2022-12-31 | -$0.92 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$2.94 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$56.85 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$67.99 10-K · filed 2024-03-26 | ||||
| 2022-09-30 | -$2.32 10-Q · filed 2023-11-09 | -$0.12 10-Q · filed 2022-11-09 | -$71.38 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$83.33 10-Q · filed 2023-11-09 | -$4.17 10-Q · filed 2022-11-09 | $8.52 derived: net income ÷ weighted average shares · filed 2024-03-26 | ||
| 2022-06-30 | -$86.72 10-Q · filed 2023-08-10 | -$4.34 10-Q · filed 2022-08-12 | -$95.31 10-Q · filed 2023-08-10 | -$4.77 10-Q · filed 2022-08-12 | $5.98 derived: net income ÷ weighted average shares · filed 2024-03-26 | $13.75 derived: net income ÷ weighted average shares · filed 2024-03-26 | ||
| 2022-03-31 | -$7.25 10-Q · filed 2023-05-15 | -$0.36 10-Q · filed 2022-05-16 | $0.54 derived: net income ÷ weighted average shares · filed 2024-03-26 | $2.04 derived: net income ÷ weighted average shares · filed 2024-03-26 | $8.94 derived: net income ÷ weighted average shares · filed 2024-03-26 | |||
| 2021-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2024-03-26 | $0.90 derived: net income ÷ weighted average shares · filed 2024-03-26 | $4.87 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$34.88 10-K · filed 2024-03-26 | -$1.74 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$0.45 10-Q · filed 2022-11-09 | -$0.93 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.39 10-Q · filed 2022-11-09 | -$39.93 derived: net income ÷ weighted average shares · filed 2023-03-30 | ||||
| 2021-06-30 | -$0.48 10-Q · filed 2022-08-12 | -$0.94 10-Q · filed 2022-08-12 | $6.33 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$42.91 derived: net income ÷ weighted average shares · filed 2023-03-30 | ||||
| 2021-03-31 | -$0.46 10-Q · filed 2022-05-16 | $1.32 derived: net income ÷ weighted average shares · filed 2023-03-30 | $6.70 derived: net income ÷ weighted average shares · filed 2023-03-30 | |||||
| 2020-12-31 | $0.26 derived: net income ÷ weighted average shares · filed 2023-03-30 | $1.46 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$50.61 10-K · filed 2023-03-30 | -$2.53 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | -$0.58 10-Q · filed 2021-11-08 | -$1.80 10-Q · filed 2021-11-08 | ||||||
| 2019-12-31 | -$4.67 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |